How do we prevent transfusion-associated graft-versus-host disease in children?

Transfusion

Volumn 51, Issue 5, 2011, Pages 916-920

  King, Karen E ^a   Ness, Paul M ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTICLE; BLOOD; BLOOD TRANSFUSION; CHILDHOOD DISEASE; ERYTHROCYTE TRANSFUSION; GAMMA IRRADIATION; HUMAN; PNEUMOCYSTIS PNEUMONIA; RADIATION DOSE; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE;

CAUSE OF DEATH; ERYTHROCYTE TRANSFUSION; FATAL OUTCOME; GAMMA RAYS; GRAFT VS HOST DISEASE; HUMANS; INFANT; PNEUMONIA, PNEUMOCYSTIS; RESPIRATORY INSUFFICIENCY; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 79955665826     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03011.x     Document Type: Article

References (20)

1. Dwyre DM, Holland PV,. Transfusion-associated graft-versus-host disease. Vox Sanguinis 2008; 95: 85-93. (Pubitemid 351951899)
2. Landfried K, Wolff D, Holler E,. Pathophysiology and management of graft-versus-host disease in the era of reduced-intensity conditioning. Curr Opin Oncol 2009; 21 Suppl 1: S39-41.
3. Alter HJ, Klein HG,. The hazards of blood transfusion in historical perspective. Blood 2008; 112: 2617-26.
4. Aoun E, Shamseddine A, CheHal A, Obeid M, Taher A,. Transfusion- associated GVHD: 10 years' experiences at the American University of Beirut-Medical Center. Transfusion 2003; 43: 1672-6. (Pubitemid 37518073)
5. Williamson LM, Stainsby D, Jones H, Love E, Chapman CE, Navarrete C, Lucas G, Beatty C, Casbard A, Cohen H,. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus host disease. Transfusion 2007; 47: 1455-67. (Pubitemid 47101067)
6. Agbaht K, Altintas ND, Topeli A, Gokoz O, Ozcebe O,. Transfusion- associated graft-versus-host disease in immunocompetent patients: case series and review of the literature. Transfusion 2007; 47: 1405-11. (Pubitemid 47101068)
7. Friedman DF, Kwittken P, Cizman B, Argyris E, Kearns J, Yang SY, Zmijewski C, Bunin N, Douglas SD, Monos D,. DNA-based HLA typing of nonhematopoietic tissue used to select the marrow transplant donor for successful treatment of transfusion-associated graft-versus-host disease. Clin Diag Lab Immunol 1994; 1: 590-6.
8. Hutchinson K, Kopko PM, Muto KN, Tuscano J, O'Donnell RT, Holland PV, Richman C, Paglieroni TG, Wun T,. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion 2002; 42: 1567-72.
9. Price TH, Standards for blood banks and transfusion services. 26th ed. Bethesda (MD): American Association of Blood Banks; 2009.
10. Roback JD, Combs MR, Grossman BJ, Hillyer CD, editors. Technical manual. 16th ed. Bethesda (MD): American Association of Blood Banks; 2008.
11. Leitman SF, Tisdale JF, Bolan CD, Popovsky MA, Klippel JH, Balow JE, Boumpas DT, Illei GG,. Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion 2003; 43: 1667-71. (Pubitemid 37518072)
12. Anderson KC, Goodnough LT, Sayers M, Pisciotto PT, Kurtz SR, Lane TA, Anderson CS, Silberstein LE,. Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood 1991; 77: 2096-101.
13. Weiss B, Hoffmann M, Anders C, Hellstern P, Schmitz N, Uppenkamp M,. Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers. Ann Hematol 2004; 83: 44-9. (Pubitemid 38088236)
14. King KE, Ness PM,. Prevention of transfusion-associated graft-versus-host disease in undiagnosed severe combined immunodeficiency syndrome. Blood 1996; 88 Suppl 1: 528a.
15. Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, Buckley RH, Eapen M, Kamani NR, O'Reilly RJ, Parkman R, Roifman CM, Sullivan KE, Filipovich AH, Fleisher TA, Shearer WT,. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol 2008; 122: 1087-96.
16. Ness PM, Lipton KS,. Selective transfusion protocols: errors and accidents waiting to happen. Transfusion 2001; 41: 713-5. (Pubitemid 32845015)
17. Anderson KC,. Broadening the spectrum of patient groups at risk for transfusion-associated GVHD: implications for universal irradiation of cellular blood components. Transfusion 2003; 43: 1652-4.
18. Ohto H, Anderson KC,. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 1996; 10: 31-43. (Pubitemid 26042556)
19. Alyea EP, Anderson KC,. Transfusion-associated graft-versus-host disease. In:, Popovsky MA, Transfusion reactions. 3rd ed. Bethesda (MD): American Association of Blood Banks; 2007 229-49.
20. Otsubo H, Yamaguchi K,. Current risks in blood transfusion in Japan. Jpn J Infect Dis 2008; 61: 427-33.